Propiedad y actividad de insiders de Benitec Biopharma Inc. (BNTC): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $11.04 |
| Capitalización | $379M |
| Bolsa | NASDAQ |
| País | US |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $17.4M | $16.2M | $22.5M | $9.8M | $19.8M | $4.1M | $2.5M | $50.9M | $97.7M | $180.0M |
| Inversiones a Corto | $76845 | $22037 | $1430 | $1000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $3.5M | $4.3M | $5.2M | $59000 | $25000 | $3000 | $55000 | $229000 | $33000 | $4000 |
| Inventario | -$65065 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $22.2M | $21.0M | $26.8M | $10.8M | $20.6M | $4.8M | $3.7M | $51.7M | $98.5M | $181.7M |
| Inmovilizado Material | $341960 | $234334 | $469227 | $769000 | $577000 | $993000 | $613000 | $449000 | $991000 | $871000 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $22.7M | $21.4M | $27.5M | $11.7M | $21.4M | $6.0M | $4.5M | $52.2M | $99.6M | $182.6M |
| Cuentas por Pagar | $133710 | $426063 | $1.5M | $282000 | $274000 | $422000 | $1.1M | $1.4M | $201000 | $913000 |
| Deuda a Corto | 0 | 0 | 0 | $192000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $864506 | $2.6M | $2.6M | $1.1M | $1.4M | $2.5M | $4.0M | $4.9M | $1.8M | $5.3M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $266000 |
| Pasivos Totales | $891402 | $2.6M | $2.6M | $1.5M | $1.4M | $3.1M | $4.3M | $5.0M | $2.3M | $5.6M |
| Reservas | -$136.2M | -$107.9M | -$108.9M | -$116.6M | -$130.1M | -$148.3M | -$167.9M | -$190.3M | -$228.2M | -$273.7M |
| Patrimonio Neto | $21.6M | $13.8M | $16.6M | $10.2M | $20.0M | $2.9M | $202000 | $47.2M | $97.3M | $177.0M |
| Deuda Total | 0 | 0 | 0 | $405000 | $213000 | $811000 | $559000 | $284000 | $849000 | $762000 |
| Deuda Neta | -$17.4M | -$16.2M | -$22.5M | -$9.4M | -$19.6M | -$3.3M | -$1.9M | -$50.6M | -$96.9M | -$179.2M |
| Capital Circulante | $21.4M | $18.4M | $24.2M | $9.7M | $19.2M | $2.3M | -$249000 | $46.8M | $96.7M | $176.3M |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 56.82 |
| Piotroski F-Score | 2 |
| Altman Z-Score | 107.24 |
Rentabilidad
| Rentabilidad sobre capital | -34.82% |
| Rentabilidad sobre capital invertido | -29.28% |
| Rentabilidad sobre activos | -26.14% |
| Margen bruto | -14.21% |
| Margen operativo | -9701.08% |
| Margen neto | -8792.09% |
Empresas relacionadas: AUTL · GALT · IMAB · LCTX · NGNE · OCGN · PRTC
Explorar sector: Healthcare · Biotechnology
Más secciones de BNTC: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones